Christoph H. Seibt, Jean Mohamed, Dirk-Jan Smit, Zach Truscott, Lasse de Vooght, Katie Bentel, Max Immerzeel, Christine Laciak
January 24, 2026
Freshfields has advised Ottobock SE & Co. KGaA in its investment in the Dutch listed NeuroTech company ONWARD Medical N.V.
1 min
AI-made summary
- Freshfields has advised Ottobock SE & Co
- KGaA on its investment in ONWARD Medical N.V., a Dutch listed NeuroTech company
- The investment is part of a Cornerstone Investment Agreement related to a capital increase announced by ONWARD
- Freshfields' international team provided legal counsel on capital market and corporate law matters for the transaction, with lawyers involved from Hamburg, Amsterdam, London, and Washington offices.
The global law firm Freshfields has advised Ottobock SE & Co. KGaA in its investment in the Dutch listed NeuroTech company ONWARD Medical N.V.. The investment is being done in the context of a Cornerstone Investment Agreement with Ottobock in connection with a capital increase announced by Onward. The international Freshfields team advised on capital market and corporate law issues relating to the investment. Partner Christoph H. Seibt and Associate Jean Mohamed (both Corporate/M&A, Hamburg); Partner Dirk-Jan Smit, Counsel Zach Truscott, Associate Lasse de Vooght (all Corporate/M&A, Amsterdam); Senior Associate Katie Bentel (Corporate/M&A, London); Senior Associate Max Immerzeel (Antitrust, Amsterdam); Special Counsel Christine Laciak (Antitrust, Washington).
Article Author
Christoph H. Seibt, Jean Mohamed, Dirk-Jan Smit, Zach Truscott, Lasse de Vooght, Katie Bentel, Max Immerzeel, Christine Laciak
The Sponsor